Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses
Moore A, Kane E, Teras L, Machiela M, Arias J, Panagiotou O, Monnereau A, Doo N, Wang Z, Slager S, Vermeulen R, Vajdic C, Smedby K, Spinelli J, Vijai J, Giles G, Link B, Arslan A, Nieters A, Bracci P, Camp N, Salles G, Cozen W, Hjalgrim H, De Vivo I, Adami H, Albanes D, Becker N, Benavente Y, Bisanzi S, Boffetta P, Brennan P, Brooks‐Wilson A, Canzian F, Clavel J, Conde L, Cox D, Curtin K, Foretova L, Ghesquières H, Glimelius B, Habermann T, Hofmann J, Lan Q, Liebow M, Lincoln A, Maynadie M, McKay J, Melbye M, Miligi L, Milne R, Molina T, Morton L, North K, Offit K, Padoan M, Piro S, Patel A, Purdue M, Ravichandran V, Riboli E, Severson R, Southey M, Staines A, Tinker L, Travis R, Wang S, Weiderpass E, Weinstein S, Zheng T, Chanock S, Rothman N, Birmann B, Cerhan J, Berndt S. Genetically determined body mass index is associated with diffuse large B‐cell lymphoma in polygenic and Mendelian randomization analyses. International Journal Of Cancer 2025 PMID: 40910475, DOI: 10.1002/ijc.70039.Peer-Reviewed Original ResearchWaist-to-hip ratioBody mass indexDiffuse large B-cell lymphomaMendelian randomization analysisRisk of diffuse large B-cell lymphomaWaist-to-hipNon-Hodgkin's lymphomaGenome-wide association studiesNon-Hodgkin lymphoma subtypesLarge B-cell lymphomaRandomization analysisGenome-wide association studies of European ancestryB-cell lymphomaStudies of European ancestryMass indexAssociated with non-Hodgkin lymphomaAssociated with diffuse large B-cell lymphomaNo significant associationPolygenic scoresMarginal zone lymphomaChronic lymphocytic leukemiaEuropean ancestrySignificant associationRisk factorsFollicular lymphoma
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply